Insulin-Producing Cell Transplantation Platform for Veterinary Practice

Insulin-Producing Cell Transplantation Platform for Veterinary Practice

Diabetes mellitus (DM) remains a global concern in both human and veterinary medicine. Type I DM requires prolonged and consistent exogenous insulin administration to address hyperglycemia, which can increase the risk of diabetes complications such as retinopathy, nephropathy, neuropathy, and heart...

Full description

Bibliographic Details
Main Authors: Suryo Kuncorojakti, Sayamon Srisuwatanasagul, Krishaporn Kradangnga, Chenphop Sawangmake
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Veterinary Science
Subjects:
diabetes mellitus
veterinary stem cell-based therapy
regenerative medicine
encapsulation
tissue engineering
Online Access:https://www.frontiersin.org/article/10.3389/fvets.2020.00004/full

Internet

https://www.frontiersin.org/article/10.3389/fvets.2020.00004/full

Similar Items